Vascular Remodeling in Health and Disease

The term vascular remodeling is commonly used to define the structural changes in blood vessel geometry that occur in response to long-term physiologic alterations in blood flow or in response to vessel wall injury brought about by trauma or underlying cardiovascular diseases.1, 2, 3, 4 The process of remodeling, which begins as an adaptive response to long-term hemodynamic alterations such as elevated shear stress or increased intravascular pressure, may eventually become maladaptive, leading to impaired vascular function. The vascular endothelium, owing to its location lining the lumen of blood vessels, plays a pivotal role in regulation of all aspects of vascular function and homeostasis.5 Thus, not surprisingly, endothelial dysfunction has been recognized as the harbinger of all major cardiovascular diseases such as hypertension, atherosclerosis, and diabetes.6, 7, 8 The endothelium elaborates a variety of substances that influence vascular tone and protect the vessel wall against inflammatory cell adhesion, thrombus formation, and vascular cell proliferation.8, 9, 10 Among the primary biologic mediators emanating from the endothelium is nitric oxide (NO) and the arachidonic acid metabolite prostacyclin [prostaglandin I2 (PGI2)], which exert powerful vasodilatory, antiadhesive, and antiproliferative effects in the vessel wall

Natural and engineered clays and clay minerals for the removal of poly- and perfluoroalkyl substances from water:State-of-the-art and future perspectives

Poly- and perfluoroalkyl substances (PFAS) present globally in drinking-, waste-, and groundwater sources are contaminants of emerging concern due to their long-term environmental persistence and toxicity to organisms, including humans. Here we review PFAS occurrence, behavior, and toxicity in various water sources, and critically discuss their removal via mineral adsorbents, including natural aluminosilicate clay minerals, oxidic clays (Al, Fe, and Si oxides), organoclay minerals, and clay-polymer and clay‑carbon (biochar and graphene oxide) composite materials. Among the many remediation technologies, such as reverse osmosis, adsorption, advanced oxidation and biologically active processes, adsorption is the most suitable for PFAS removal in aquatic systems. Treatment strategies using clay minerals and oxidic clays are inexpensive, eco-friendly, and efficient for bulk PFAS removal due to their high surface areas, porosity, and high loading capacity. A comparison of partition coefficient values calculated from extracted data in published literature indicate that organically-modified clay minerals are the best-performing adsorbent for PFAS removal. In this review, we scrutinize the corresponding plausible mechanisms, factors, and challenges affecting the PFAS removal processes, demonstrating that modified clay minerals (e.g., surfactant, amine), including some commercially available products (e.g., FLUORO-SORB®, RemBind®, matCARE™), show good efficacy in PFAS remediation in contaminated media under field conditions. Finally, we propose future research to focus on the challenges of using clay-based adsorbents for PFAS removal from contaminated water due to the regeneration and safe-disposal of spent clay adsorbents is still a major issue, whilst enhancing the PFAS removal efficiency should be an ongoing scientific effort

SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settings

Neuroblastoma is the most common extracranial solid tumor in childhood in high‐income countries (HIC), where consistent treatment approaches based on clinical and tumor biological risk stratification have steadily improved outcomes. However, in low‐ and middle‐ income countries (LMIC), suboptimal diagnosis, risk stratification, and treatment may occur due to limited resources and unavailable infrastructure. The clinical practice guidelines outlined in this manuscript are based on current published evidence and expert opinions. Standard risk stratification and treatment explicitly adapted to graduated resource settings can improve outcomes for children with neuroblastoma by reducing preventable toxic death and relapse. Pediatr Blood Cancer 2015;62:1305–1316. © 2015 The Authors. Pediatric Blood & Cancer, published by Wiley Periodicals, Inc